© 1979


  • Rafael A. Camerini-Davalos
  • Bernard Hanover

Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 119)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Early Diabetes: Definition, Present Concept

    1. R. A. Camerini-Davalos
      Pages 1-6
    2. P. J. Savage, R. F. Hamman, P. H. Bennett
      Pages 13-19
    3. Rafael A. Camerini-Davalos, Bernard Hanover
      Pages 29-32
  3. Genetic Influences on Islet Cell Function

    1. HLA System

      1. L. P. Ryder, M. Christy, J. Nerup, P. Platz, A. Svejgaard, M. Thomsen
        Pages 41-48
      2. Rafael A. Camerini-Davalos, Bernard Hanover
        Pages 49-50
    2. Familial Patterns of Inheritance

      1. J. Barbosa, M. M. Chern
        Pages 51-57
      2. Rafael A. Camerini-Davalos, Bernard Hanover
        Pages 67-69
  4. Metabolic Aspects of Islet Cell Function

  5. Abnormal Development of the Pancreas

    1. Rafael A. Camerini-Davalos, Bernard Hanover
      Pages 123-123
  6. Environmental Factors Influencing Islet Cell Function

    1. Nutritional

      1. D. E. Schteingart, A. K. McKenzie, R. S. Victoria, H. S. Tsao
        Pages 125-132

About this book


To obey the precepts of therapeutic rationality, we should avoid treating the "effect" when there is a way to attack the cause. But what is the cause of diabetes? Diabetes is a molecular disease, that is, a disease in which important cellular components are seriously impaired. Eventually, the activities or the products arising from the impairment find expression in various ways, finally culminating in the abnormalities of diabetes. How early is early enough to attempt to delay this sequence of events? What will provide us with the basis to explore ways and means of halting the progression of the pathological process? What are the new approaches for the treatment of early diabetes? The Fourth International Symposium on Early Diabetes, sponsored by the Diabetes Center of the New York Medical College, held in Algarve, Portugal in November 1978, from which this book evolved, attempted to answer some of these questions. A list of the participants, including their affiliations, will be found preceding the index. Rafael A. Camerini-Davalos v Acknowledgments To our sponsors, U.S.V. Pharmaceutical Corp., Pfizer Pharmaceuticals, Ames Company, Hoechst, Frankfurt; supporters, Boehringer, Manheim, Laboratoires Servier, Nordisk Laboratory, The Upjohn Company, Eli Lilly and Company, F. Hoffman La Roche; and contributors, Bayer A. G. Leverkusen, McNeil, Novo Research Institute, ICI Belgium, Hope for Diabetics Foundation, New York, we express our appreciation for the financial support which made possible the Fourth International Symposium on Early Diabetes. THE ORGANIZING COMMITTEE Rafael A. Camerini-Davalos, M.D.


Insulin Secretion Laboratory Pancreas Pancreatic Islets diabetes diabetes mellitus diabetic neuropathy insulin metabolism nutrition research treatment

Editors and affiliations

  • Rafael A. Camerini-Davalos
    • 1
  • Bernard Hanover
    • 1
  1. 1.Diabetes CenterNew York Medical CollegeNew YorkUSA

Bibliographic information

  • Book Title Treatment of EARLY DIABETES
  • Editors R. Camerini-Davalos
  • Series Title Advances in Experimental Medicine and Biology
  • DOI
  • Copyright Information Springer-Verlag US 1979
  • Publisher Name Springer, Boston, MA
  • eBook Packages Springer Book Archive
  • Hardcover ISBN 978-0-306-40194-7
  • Softcover ISBN 978-1-4615-9112-2
  • eBook ISBN 978-1-4615-9110-8
  • Series ISSN 0065-2598
  • Edition Number 1
  • Number of Pages XVI, 532
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Diabetes
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Internal Medicine & Dermatology